Although previous studies have established PSMs as an independent prognostic factor for BCR in patients with prostate cancer treated with RP [6,7,8], the prognostic significance of PSM location remains a point of clinical attention in the context of RP. The gene discussed is BCR; the disease is Familial prostate cancer.